Popular on EntSun
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates - 416
- Stitt Entertainment Names Tristan Xavier Lead Stylist - 347
- ChargeOn Announces Conversational Payment Management Solution - 344
- Mecca to Mars: Earth's Escape? - 255
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 233
- Rehearsals Begin on 'The Call List' by Brian James Polak - 221
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 218
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING - 205
- Big Panic Records Announces "African Sunshine" by Believe, Shirley Jones & Omasta - 202
- Yalil Guerra's "Clave" to Receive World Premiere in New Symphonic Version at The Soraya - 186
Similar on EntSun
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
Reach IPS partners with VistaLifeSciences to use i360 in South Africa
EntSun News/10743769
Reach IPS Partners with VistaLifeSciences to Provide Comprehensive Solutions for Remote Patient Monitoring
CUPERTINO, Calif. - Aug. 8, 2018 - EntSun -- California based Reach IPS and Parker CO based VistaLifeSciences, Inc. announced that they have signed a letter of intent/MOU to integrate their technologies to provide a comprehensive treatment solution for remote patient monitoring in South Africa.
VistaLifeSciences's proprietary clinical pathways and EHR software improves real time event management at the point-of-care. They provide intelligent analytics and support to doctors, and healthcare professionals (Nurse Practitioners, Physician Assistants, and other clinicians) to enhance the lives of patients with various disease states including HIV.
Reach IPS i360 is a mobile healthcare iOT system that allows health and wellness providers to deliver effective clinical care plans through a modern consumer wearable devices. Inside its delivery system, i360 features a platform that collects and analyzes a wide range of block chain data available through various medical devices. Team this technology up with the ability to connect and monitor multiple patient centric devices which deliver a complete patient performance assessment as well as multiple care plan protocols specific to the user.
More on EntSun News
"VistaLifeSciences is excited to partner with Reach IPS for their i360 technologies. With the proper device data integration with our patient centric-spectrum differential algorithms, we will provide quicker and more accurate diagnoses for a specific disease syndrome, thus reducing health care costs for hospitals, enabling doctors and remote clinical care to provide personalized medicine, and to improve the quality of life for their patients." –Peg Molloy, Chief Strategy Officer and Co-founder of VistaLifeSciences, Inc.
David A Wanner, MBA/MHA., Chief Administrative Officer of Reach IPS added, "We at Reach IPS are very excited about collaborating with VistaLifeSciences. We are all about creating digital health opportunities to enhance patient lives worldwide and create increased provider efficacy. This is a primary value statement for both entities. VistaLifeSciences is pioneering remote mobile symptom tracking, and diagnostic categorization application and Reach IPS cutting-edge i360 advanced patient monitoring push forward increased diagnostic accuracy from remote and wearable devices.
Both companies are leaders in their respective verticals and together create significant potential for the industry and patient."
About VistaLifeSciences
More on EntSun News
VistaLifeSciences offers clinical decision support, patient assessment and EHR software for use at point-of-care and in telemedicine. Healthcare professionals, from physicians to community health workers, use our software to improve patient lives by expediting the time to proper diagnosis, care and management. Our Apps standardize data collection, provide guided easy-to-use data capture, and include patented, peer-reviewed and globally used patient assessment tools. We improve workflow, consistency, patient experience and, most importantly, reduce misdiagnosis. Learn more at www.VistaLifeSciences.com
About Reach IPS
Reach IPS is a digital health innovator, building the bridge between wearable devices and patient care. i360 provides hundreds of predefined treatment plans, with the ability to customize, combine and manage any number of devices, caregivers and patient groups, while using your EMR/EHR software of choice. 360 supports almost every biomedical and fitness/wearable device while integrating into most leading EMR systems. i360 promotes healthier lifestyles without making lifestyle changes.
Visit www.ReachIPS.com to learn more.
Contact
David Wanner
dwanner@reachips.com
VistaLifeSciences's proprietary clinical pathways and EHR software improves real time event management at the point-of-care. They provide intelligent analytics and support to doctors, and healthcare professionals (Nurse Practitioners, Physician Assistants, and other clinicians) to enhance the lives of patients with various disease states including HIV.
Reach IPS i360 is a mobile healthcare iOT system that allows health and wellness providers to deliver effective clinical care plans through a modern consumer wearable devices. Inside its delivery system, i360 features a platform that collects and analyzes a wide range of block chain data available through various medical devices. Team this technology up with the ability to connect and monitor multiple patient centric devices which deliver a complete patient performance assessment as well as multiple care plan protocols specific to the user.
More on EntSun News
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Creative Abundance Has Made Conviction Scarce
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
"VistaLifeSciences is excited to partner with Reach IPS for their i360 technologies. With the proper device data integration with our patient centric-spectrum differential algorithms, we will provide quicker and more accurate diagnoses for a specific disease syndrome, thus reducing health care costs for hospitals, enabling doctors and remote clinical care to provide personalized medicine, and to improve the quality of life for their patients." –Peg Molloy, Chief Strategy Officer and Co-founder of VistaLifeSciences, Inc.
David A Wanner, MBA/MHA., Chief Administrative Officer of Reach IPS added, "We at Reach IPS are very excited about collaborating with VistaLifeSciences. We are all about creating digital health opportunities to enhance patient lives worldwide and create increased provider efficacy. This is a primary value statement for both entities. VistaLifeSciences is pioneering remote mobile symptom tracking, and diagnostic categorization application and Reach IPS cutting-edge i360 advanced patient monitoring push forward increased diagnostic accuracy from remote and wearable devices.
Both companies are leaders in their respective verticals and together create significant potential for the industry and patient."
About VistaLifeSciences
More on EntSun News
- ALVIN Challenges the Closed Future of Streaming Television
- Army Claims 2026 Top Dog Title as Rally4Vets Debuts at Dominion Raceway
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- Birthday of the World Children's Theatre Experience Brings Jewish Storytelling and Imagination
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
VistaLifeSciences offers clinical decision support, patient assessment and EHR software for use at point-of-care and in telemedicine. Healthcare professionals, from physicians to community health workers, use our software to improve patient lives by expediting the time to proper diagnosis, care and management. Our Apps standardize data collection, provide guided easy-to-use data capture, and include patented, peer-reviewed and globally used patient assessment tools. We improve workflow, consistency, patient experience and, most importantly, reduce misdiagnosis. Learn more at www.VistaLifeSciences.com
About Reach IPS
Reach IPS is a digital health innovator, building the bridge between wearable devices and patient care. i360 provides hundreds of predefined treatment plans, with the ability to customize, combine and manage any number of devices, caregivers and patient groups, while using your EMR/EHR software of choice. 360 supports almost every biomedical and fitness/wearable device while integrating into most leading EMR systems. i360 promotes healthier lifestyles without making lifestyle changes.
Visit www.ReachIPS.com to learn more.
Contact
David Wanner
dwanner@reachips.com
Source: Reach IPS & VistaLifeSciences
0 Comments
Latest on EntSun News
- Luther Relives Brings an Outstanding Tribute to Luther Vandross to the Weinberg Center this October
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- Most Indiana Plane Crashes Happen Away from the State's Major Airports
- L2 Aviation Welcomes Jason Marshall as Vice President of Sales and Business Development
- Mom Era, Still That Girl: Family Art Tees 25% Off
- Movie Meltdown Joins Weirding Way Media
- Fashion vs. Fascism - Because Democracy Should Always Be In Style
- Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast
- KayeDinero Takes "Appalachia" Above the Blue Ridge With New Aerial Music Visual
- Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Lovecraft In Florida Blu-Ray Release
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- Events by Dubsdread Celebrates Cultural Traditions with New Guide on Faith-Based Wedding Traditions Across Cultures
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Get The Led Out Bring an Outstanding Tribute to Led Zeppelin to the Weinberg Center
- Cemetery Cinema is now available for Syndication!!!!
- Notaron Expands Online Notarization Access Following Wisconsin Approval
